Quality-of-Life Changes in Patients with Thyroid Cancer After Withdrawal of Thyroid Hormone Therapy

DOW, KAREN HASSEY, FERRELL, BETTY R., ANELLO, CAROL·1997·Thyroid
DOI 10.1089/thy.1997.7.613

Cited by (289)

Items 201–289 of 289

  1. Study Protocol of Expanded Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro-EXP)
    Jae Hoon Moon, Eun Kyung Lee, Wonjae Cha, Young Jun Chai, Sun Wook Cho, June Young Choi, Sung Yong Choi, A Jung Chu, Eun‐Jae Chung, Yul Hwangbo et al. · 2025 · Endocrinology and Metabolism
  2. Comparison of the Effectiveness Between a Single Low Dose and Fractionated Doses of Radioiodine in Ablation of Post-operative Thyroid Remnants
    Guang‐Uei Hung · 2004 · Japanese Journal of Clinical Oncology
  3. Recombinant Human TSH–Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal
    Matthias Schott · 2008 · Yearbook of Endocrinology
  4. Follow-up of Patients with Differentiated Thyroid Carcinoma
    Martin Jean Schlumberger, Sophie Leboulleux, Furio Pacini · 2006 · Springer eBooks
  5. RECOMBINANT HUMANE THYROTROPIN (RHTSH) A NEW AID IN THE DIAGNOSIS AND TREATMENT OF THYROID CARCINOMA WITH RADIO-IODINE
    Boudewijn T. Brans, Filip Gemmel, Olivier Winter, Tom Fiers, Joseph De Roose, Hubert Vermeersch, R. Rubens, JM Kaufman, Rudi Dierckx · 2001 · Acta Clinica Belgica
  6. Guidelines for the Use of Radio-iodine, Thyroid Hormone, and Treatment of Metastatic Disease in Patients With Differentiated Thyroid Cancer
    Edward Paloyan, Regina Paloyan Walker, A M Lawrence · 1998 · Surgical Oncology Clinics of North America
  7. Prognostic Factors for Thyroid Carcinoma Originating from Follicular Cells
    Yasuhiro Ito, Bryan McIver, Nikola Bešič, Amit Agarwal · 2011 · Journal of Thyroid Research
  8. Impacto de la medicina nuclear en el diagnóstico y tratamiento del cáncer diferenciado de tiroides
    Sevastián Medina-Ornelas, Francisco O. García-Pérez, Martín Granados García · 2018 · Gaceta Médica de México
  9. Postoperative rehabilitation and quality of life evaluation for transoral endoscopic thyroidectomy vestibular approach
    Yu Mao, Shiwei Zhou, Peng Yu Wu, Wu Li, Hui Li, Zhiyuan Wang, Xibin Xia, Xiaohua Song, Mingming Wang, Xiaowei Peng · 2024 · Scientific Reports
  10. Health services research in endocrine surgery
    Sanziana A. Roman, Leon D. Boudourakis, Julie Ann Sosa · 2008 · Current Opinion in Oncology
  11. Recombinant human thyroid‐stimulating hormone versus thyroid hormone withdrawal preparation for radioiodine ablation in differentiated thyroid cancer in children, adolescents and young adults
    Max A. Schumm, Howard Q. Pyo, Jiyoon Kim, Chi‐Hong Tseng, Michael W. Yeh, Angela M. Leung, Harvey Kenn Chiu · 2021 · Clinical Endocrinology
  12. Preparation for radioiodine therapy in patients with differentiated thyroid cancer: a modern perspective (a review)
    Maria V. Reinberg, Konstantin Yu. Slashchuk, А. А. Трухин, Karina I. Avramova, М. С. Шеремета · 2023 · Digital Diagnostics
  13. Comparative Effectiveness in Thyroid Cancer: Key Questions and How to Answer Them
    Elliot Amponsah Asare, Tracy S. Wang · 2015 · Cancer treatment and research
  14. Sensitivity of preparation with rhTSH or thyroid hormone withdrawal using 131 I-whole body scans to identify metastases of differentiated thyroid cancer
    Knut Liepe · 2015 · International Journal of Surgery
  15. Thyroglobulin as Specific Tumor Marker in Differentiated Thyroid Cancer
    Rainer Görges, A. Bockisch · 2005 · Springer eBooks
  16. Short-term hypothyroidism in thyroid cancer patients and cognitive-motor performance relevant for driving
    Ernst Lodemann, Andreas Bockisch, Rainer Görges · 2012 · Psychoneuroendocrinology
  17. Uso do TSH humano recombinante no câncer diferenciado de tireóide
    Hans Graf, Gilberto Paz-Filho · 2007 · Arquivos Brasileiros de Endocrinologia & Metabologia
  18. Short-term severe thyroid hormone deficiency does not influence sleep parameters
    Christian Jeffrey Koehler, Christian Ginzkey, Norbert H Kleinsasser, Rudolf Hagen, Christoph Reiners, Frederik A. Verburg · 2012 · Sleep And Breathing
  19. Differentiated Thyroid Cancer: Radioiodine Therapy
    Frederik A. Verburg · 2020 · Springer eBooks
  20. Psychosocial Factors in Patients with Thyroid Disease
    Petra Mandincov · 2012 · InTech eBooks
  21. Use of recombinant human thyroid-stimulating hormone in the management of well-differentiated thyroid cancer
    MARIUS E. KRAENZLIN, Christian Meier · 2006 · Expert Opinion on Biological Therapy
  22. Follow-Up of Low-Risk Differentiated Thyroid Cancer Patients Who Underwent Radioiodine Ablation of Postsurgical Thyroid Remnants after Either Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal
    Matthias Schott, Sven Schinner · 2010 · Yearbook of Endocrinology
  23. Actualités en endocrinologie thyroïdienne
    Patrice Rodien, A. Bourdelot, Frédérique Savagner · 2004 · EMC - Endocrinologie
  24. The Need for a Low-Expense Universally Acceptable rhTSH Protocol
    Manish Ora, P Madhusudanan, Suruchi Jain, Sukanta Barai, Sanjay Gambhir · 2011 · Journal of Nuclear Medicine
  25. Voice Outcome of Total Thyroidectomy in Comparison With Administration of Recombinant Human TSH
    Yong Tae Hong, Seok Tae Lim, Ki Hwan Hong · 2019 · Journal of Voice
  26. Can the basal serum thyroglobulin level be used to predict the recombinant human TSH-stimulated thyroglobulin level in differentiated patients with thyroid cancer?
    Eugene Jeong, Joon‐Kee Yoon, Su Jin Lee, Euy Young Soh, Jeonghun Lee, Hyeung Kyoo Kim, Young‐Sil An · 2019 · Medicine
  27. A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial Protocol
    Eun Kyung Lee, You Jin Lee, Young Joo Park, Jae Hoon Moon, Ka Hee Yi, Koon Soon Kim, Joo Hee Lee, Sun Wook Cho, Jungnam Joo, Yul Hwangbo et al. · 2020 · Endocrinology and Metabolism
  28. Brain [18F]Fluorodeoxyglucose Metabolism Assessment under Hypothyroidism and Recombinant Human Thyroid-Stimulating Hormone in Comparison with Thyroid Hormone Replacement in Patients Submitted to Total Thyroidectomy
    Sílvia D. Almeida, Francisco P. M. Oliveira, María José Oliveira, Jose Joselito Ferreira de Oliveira, Rita Afonso, Diogo Borges Faria, Durval C. Costa · 2022 · Applied Sciences
  29. Thyroid hormone replacement one day before (131)I therapy in patients with well-differentiated thyroid cancer.
    Daiki Kayano, Junichi Taki, Anri Inaki, Hiroshi Wakabayashi, Ayane Nakamura, Makoto Fukuoka, Seigo Kinuya · 2013 · PubMed Central
  30. Recombinant Human Thyrotropin
    Matthew David Ringel, Stephen J. Burgun · 2016 · Springer eBooks
  31. Factors Influencing the quality of life in thyroid cancer patients after thyroidectomy
    Jeong-Sook Jeong, In‐Sook Kim, Eun-Seon Lee · 2015 · Journal of the Korea Academia-Industrial cooperation Society
  32. An easy schedule for postsurgical radioiodine administration in newly diagnosed differentiated thyroid carcinoma patients
    Giovanni Lupoli, Maria Rita Poggiano, Annalisa Panico, Luciana Granieri, Roberta Lupoli, Marianna Cacciapuoti, Giovanni Lupoli · 2012 · Clinical Endocrinology
  33. Severe Short-Term Hypothyroidism Is Not Associated with an Increased Incidence of Myocardial Ischemia as Assessed by Thallium-201 Stress/Rest Myocardial Scintigraphy
    Franz Prasch, SILVIA WOGRITSCH, Ingrid Hurtl, CHRISTA HOLM, C Najemnik, Robert Dudczak · 1999 · Thyroid
  34. Radioiodine Therapy of Thyroid Cancer
    Frederik A. Verburg · 2019 · Springer eBooks
  35. Follow-Up of Low-Risk Differentiated Thyroid Cancer Patients Who Underwent Radioiodine Ablation of Postsurgical Thyroid Remnants after Either Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal
    M. Schott, S. Schinner · 2010 · Yearbook of Medicine
  36. [Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences].
    Kornelia Hasse-Lazar, Daria Handkiewicz-Junak, Józef Roskosz, Sylwia Szpak‐Ulczok, Jolanta Krajewska, Beata Jurecka‐Lubieniecka, Barbara Jarząb · 2006 · PubMed
  37. Recombinant Human TSH (rhTSH): Use in Papillary and Follicular Thyroid Cancer
    Furio Pacini, Martin Jean Schlumberger · 2006 · Springer eBooks
  38. Metastatic papillary thyroid cancers with malignant pleural effusion aggravated during thyroid hormone withdrawal for radioiodine therapy
    Ji Hye Seo, Ji Hye Je, Hyun Jung Lee, Young Ju Na, Il Woo Jeong, Jee Hyun An, Sin Gon Kim, Dong Seop Choi, Nam Hoon Kim · 2015 · Journal of Yeungnam Medical Science
  39. Health-Related Quality of Life Among Thyroid Cancer Survivors in India: Insights from the Modified City of Hope-QOL Thyroid Version Questionnaire
    Sushil Raj Shrestha, Madhu Priya, G. Vetrivel, Manu Malhotra, Abhishek Bhardwaj, Saurabh Varshney, Amit Kumar, Amit Kumar Tyagi, Gaurav Kumar Goldar · 2025 · Indian Journal of Surgical Oncology
  40. Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer: Protocol of a Multicenter Cluster-Randomized Trial (MAeSTro-SDM)
    Eun Kyung Lee, Min Joo Kim, Yul Hwangbo, Jae Hoon Moon, Sun Wook Cho, Young Jun Chai, June Young Choi, Yuh‐Seog Jung, Kyu Eun Lee, Eun‐Jae Chung et al. · 2026 · Journal of Korean Medical Science
  41. Hypothyroidism and Radioiodine Therapy
    Otakar Kraft · 2012 · InTech eBooks
  42. Identification of Intermediate- to High-Risk Papillary Thyroid Carcinoma Patients Who May Be Safely Managed without the Performance of Delayed Stimulated Thyroglobulin Measurements following Total Thyroidectomy and Radioactive Iodine Therapy
    Kyung‐Hee Kim, Min-Hee Kim, Ye-Jee Lim, Ihn Suk Lee, Ja Seong Bae, Dong-Jun Lim, Ki Hyun Baek, Jong Min Lee, Moo-Il Kang, Bong Yun Cha · 2015 · International Journal of Endocrinology
  43. Value of the Serum Thyroglobulin Level Alteration at the First High Dose Radioiodine Treatment in Patients with Differentiated Thyroid Carcinoma
    남현열, 김인주, 김용기, 김성장, 전성민, 김범수 · 2009 · Nuclear Medicine and Molecular Imaging
  44. [Assessment of the quality of life in patients with differentiated thyroid carcinoma during a one-month withdrawal of levorotatory thyroxine preparations (L-T4) before a control diagnostics].
    Monika Szymonek, Iwona Pałyga, Danuta Gąsior‐Perczak, Aldona Kowalska · 2006 · PubMed
  45. Coste-efectividad de la utilización de la tirotropina recombinante humana previa a la ablación con radioyodo en el tratamiento del cáncer de tiroides en hospitales españoles
    Juan Antonio Vallejo, Maria Angustias Muros · 2017 · Revista Española de Medicina Nuclear e Imagen Molecular
  46. Surveillance Strategies After Initial Treatment of Differentiated Thyroid Cancer
    Deepa Kirk · 2017 · Springer eBooks
  47. RETRACTED: Detection of TSH, FT3, FT4, and TRAb in ovarian cancer with highly sensitive electrochemical immunoassay
    Maoben Yang, Xiaojun Guo · 2018 · European Journal of Inflammation · Retracted
  48. Recombinant Human Thyrotropin
    Matthew David Ringel, Stephen J. Burgun · 2006 · Humana Press eBooks
  49. Clinical Radionuclide Therapy
    Andrew Mark Scott, Sze Ting Lee · 2008 · Springer eBooks
  50. Nuclear medicine and differentiated thyroid cancer
    Sevastián Medina-Ornelas, Francisco O. García-Pérez, Martín Granados García · 2018 · Gaceta Mexicana de Oncología
  51. Guía de manejo del nódulo tiroideo y del cáncer diferenciado de tiroides de la Sociedad Mexicana de Oncología
    Martín Granados García, José F. Gallegos-Hernández, Héctor Gurrola-Machuca, Lorena Flores‐Hernández, Irlanda Pacheco‐Bravo, Michelle Aline Villavicencio-Queijeiro, Francisco O. García-Pérez, Juan Carlos Cruz-López, Mónica Lizzette Serrano-Arévalo, Lidia Faridi-Villegas et al. · 2018 · Gaceta Mexicana de Oncología
  52. Thyroid Cancer: Diagnosis, Treatment and Follow-Up
    Mira Valentinova Siderova · 2019 · IntechOpen eBooks
  53. The Role of the Clinical Psychologist
    Katherine Kendell · 2006 · Springer eBooks
  54. Una década de tirotropina recombinante humana
    Beatriz Rodríguez-Merchán, Jordi Mesa · 2009 · Medicina Clínica
  55. Utilidad de la TSH recombinante en el diagnóstico y tratamiento de las enfermedades tiroideas
    I. Halperin Rabinovich · 2003 · Endocrinología y Nutrición
  56. The Effect of Thyroid Hormone Withdrawal, Performed to Evaluate the Success of I-131 Ablation, On Quality of Life in Female Patients With Low-Risk Differentiated Thyroid Cancer
    Osman Kupik, Bayram Şen, Medeni Arpa, Levent Akça, Uğur Avcı, Gülnihan Eren, Hasan Gündoğdu, Süleyman Kalcan, Hasan Güçer, Şafak Akın et al. · 2021 · Research Square
  57. Recombinant Human Thyrotropin
    Matthew David Ringel · 2000 · Humana Press eBooks
  58. Thyroid Cancer and the Endocrinologist
    Wilmar M. Wiersinga · 2006 · Springer eBooks
  59. Thyroid Cancer and the General Practitioner
    Geoffrey Keith Mitchell, Duncan Leith · 2006 · Springer eBooks
  60. Recurrence Rate of Tumor and the Value of Diagnostic I-131 Whole Body Scintigraphy and Recombinant TSH in Low-Risk Well Differentiated Thyroid Cancer Patients Who Have Had I-131 Radioablation
    Murat Argon, Ülkem Yararbaş, Kamil Kumanlıoğlu, Hayal Özkılıç · 2012 · Turkiye Klinikleri Journal of Medical Sciences
  61. The THYCA-QoL Questionnaire Can Be Used to Measure Health-Related Quality of Life in Thyroid Cancer Survivors
    Cord Sturgeon · 2014 · Clinical Thyroidology
  62. ПСИХОЛОГИЧЕСКАЯ РЕАБИЛИТАЦИЯ И ОЦЕНКА КАЧЕСТВА ЖИЗНИ БОЛЬНЫХ РАКОМ щИТОВИДНОЙ ЖЕЛЕЗЫ
    С В Дубский, Куприянова Ирина Евгеньевна, Е. Л. Чойнзонов, Lidiya Nikolaevna Balatskaya · 2008 · Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale
  63. The Role of the Specialist Nurse
    Caroline Owen-Hafiz · 2006 · Springer eBooks
  64. Dépistage des récidives des cancers différenciés de la thyroïde sous TSH recombinante (Thyrogen®) : évolution de la TSH et de la thyroglobuline
    Kalyane Bach‐Ngohou, A. Bettembourg, Gabriel Ricolleau, Françoise Kraeber‐Bodéré, Olivier Couturier, Patrick LUSTENBERGER, Damien Masson, Marc Guillaume Denis · 2003 · Immuno-analyse & Biologie Spécialisée
  65. Thyroid remnant ablation in differentiated thyroid carcinoma: when and how
    Frederik A. Verburg, Heribert Hänscheid, Markus Luster · 2013 · Clinical and Translational Imaging
  66. Les besoins des membres de la famille lorsqu’un proche suit un traitement à l’iode radioactif
    Margaret I. Fitch, Petrina N. McGrath · 2003 · Canadian Oncology Nursing Journal
  67. Utilidad de la tiroglobulina plasmática tras TSH humana recombinante en el cáncer diferenciado de tiroides libre de enfermedad
    Pedro López Mondéjar, A. López, M. F. Mauri, Rocı́o Alfayate, Óscar Moreno, Antonio Miguel Pico, Alberto Martín-Hidalgo · 2006 · Endocrinología y Nutrición
  68. Thyroid Hormone Treatment for Differentiated Thyroid Carcinoma: What Drug, How Long, What Dose?
    Eliana Piantanida, Emanuele Compri, Myriam Gandolfo, Lorenza Sassi, Gianlorenzo Dionigi, Adriana Lai, Maria Laura Tanda, Luigi Bartalena · 2009 · Current Cancer Therapy Reviews
  69. Life-Threatening Hypothyroidism During Thyroid Hormone Withdrawal for Routine Thyroid Cancer Surveillance
    Philip A. Goldberg · 2007 · The Endocrinologist
  70. A Retrospective Review of the Effectiveness of Recombinant Human TSH-Aided Radioiodine Treatment of Differentiated Thyroid Carcinoma
    Min Ah Na, Sun Hae Shin, Yang Ho Kang, Seok Man Son, In Joo Kim, Yong Ki Kim · 2006 · Journal of Korean Endocrine Society
  71. rhTSH-aided Radioiodine Treatment in Differentiated Thyroid Carcinoma
    Kyung Rae Kim · 2006 · Journal of Korean Endocrine Society
  72. recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer
    Clinical S Tudy, Massimo Torlontano, Umberto Crocetti, Nazario Bonfitto, Anna Di Giorgio, Sergio Modoni, Guido Valle, Vincenzo Frusciante, Michele Bisceglia, Sébastiano Filetti et al. · 2003
  73. Usporedba različitih doza joda 131 u ablaciji ostatnog tkiva štitnjače zbog papilarnog karcinoma, te uloga rekombinantnog humanog tireotropina (rhTSH) kod ablacije
    Medicinski Fakultet · 2010
  74. Health-related quality of life—an economist's perspective
    Gérard de Pouvourville, Isabelle Borget, Martin Jean Schlumberger · 2007 · Nature Clinical Practice Endocrinology &#38 Metabolism
  75. Risk factors associated with high thyroglobulin level following radioactive iodine ablation, measured 12 months after treatment for papillary thyroid carcinoma
    Eun Young Kim, Keehoon Hyun, Yong Lai Park, Chan Heun Park, Ji‐Sup Yun · 2017 · Annals of Surgical Treatment and Research
  76. La medicina nuclear y el cáncer diferenciado de tiroides
    Sevastián Medina-Ornelas, Francisco O. García-Pérez, Martín Granados García · 2017 · Gaceta Mexicana de Oncología
  77. Nuclear medicine impact on differentiated thyroid cancer diagnosis and treatment
    Sevastián Medina-Ornelas, Francisco O. García-Pérez, Martín Granados García · 2018 · Gaceta Médica de México
  78. Effects of Surgical Operation and Induced Thyroid Hormone Deficiency During Cancer Treatment on Emotional Distress in Thyroid Cancer Patients
    김종선, Won‐Jung Choi, Hang‐Seok Chang, Yong Sang Lee, 오영자, Jeong‐Ho Seok · 2012
  79. Change of Therapeutic Response Classification According to Recombinant Human Thyrotropin-Stimulated Thyroglobulin Measured at Different Time Points in Papillary Thyroid Carcinoma
    Jang Bae Moon, Subin Jeon, Ki Seong Park, Su Woong Yoo, Sae‐Ryung Kang, Sang‐Geon Cho, Jahae Kim, Changho Lee, Ho‐Chun Song, Jung‐Joon Min et al. · 2021 · Nuclear Medicine and Molecular Imaging
  80. Thyroglobulin
    Carole Ann Spencer, Shireen Fatemi · 2006 · Springer eBooks
  81. Differentiated Thyroid Cancer
    2006 · Springer eBooks
  82. Le cancer : approche psychodynamique chez l’adulte
    2004 · Érès eBooks
  83. The effect of thyroid hormone withdrawal performed to evaluate the success of I-131 ablation on quality of life and psychological symptoms in female patients with low-risk differentiated thyroid cancer
    Osman Kupik, Bayram Şen, Medeni Arpa, Levent Akça, Uğur Avcı, Gülnihan Eren Kupik, Hasan Güçer, Süleyman Kalcan, Hasan Güçer, Şafak Akın et al. · 2023 · Journal of Health Sciences and Medicine
  84. THYROID STIMULATING HORMONE EVALUATION BETWEEN THREE AND FOUR WEEKS OF LEVOTHYROXINE WITHDRAWAL IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA
    Mohammad Fitri Khalil, Khadijah Abdul Hamid, Fadzilah Hamzah · 2023 · Journal of Health and Translational Medicine
  85. Cosmetic and Quality of Life Outcomes of Supraclavicular vs Conventional Thyroidectomy Incisions in Unilateral Papillary Thyroid Carcinoma
    Jong‐Lyel Roh · 2025 · Aesthetic Plastic Surgery
  86. Recombinant Human Thyrotropin in the Management of Thyroid Carcinoma and Other Thyroid Disorders
    Steven I. Sherman, Luis Lopez‐Penabad · 2003 · Humana Press eBooks
  87. Allostatic load in thyroid cancer is higher than that of other cancers: A secondary analysis using NHANES
    Wen-rui Wang, Guan-dong Liu, Dong-xiao Ren, Xiaoyu Liu · 2026 · PLoS ONE
  88. Quality of Life Following Cancer of the Thyroid Gland
    Diane Bijou, Christopher de Souza, Vishal Tyagi, Preeti Dhingra, Rosemarie de Souza, Aishan Patil, A A.C. Patil · 2026 · Springer eBooks
  89. The Thyroid Cancer Modified Anxiety Scale (TC-MAX): Development and External Validation of a Thyroid Cancer Distress Instrument
    Amanda J. Bastien, Sungjin Kim, Cynthia Zalt, Iris Cong, Jewel Ng, Caroline Marshall, Christopher V. Almario, Omer Liran, Brennan MR Spiegel, Jon Mallen‐St. Clair et al. · 2026 · Thyroid